Gilead Sciences, a Foster City, California-based biopharmaceutical company, is scheduled to present new AI-powered research related to nonalcoholic steatohepatitis (NASH) at The Liver Meeting 2019 in Boston.

Deep learning techniques have shown potential to change cardiac MRI forever, according to a new analysis published in the American Journal of Roentgenology. However, the authors wrote, it is also important to remember deep learning’s current limitations.

RadNet has announced a new partnership with Santa Clara, California-based Whiterabbit.ai to improve mammography screening rates and breast cancer care through the use of AI and other advanced technologies.

It is traditionally believed that men and women experience angina—the pain associated with coronary artery disease—in different ways, with men feeling it in their chest and women feeling it in their arms and back.

PathAI, a Boston-based healthcare technology company, has found that AI can help specialists quantify PD-L1 expression on both tumor cells and immune cells.

Cancer Research UK, one of the world’s largest charities focused on improving cancer treatments, has launched a new research network focused on advanced radiotherapy techniques, immunotherapies and AI.

Researchers from the University at Buffalo in New York are working to turn a $200,000 grant into groundbreaking diabetes research.

Numerous healthcare providers and technology companies are working together on a new research project focused on using AI to improve care for patients with subarachnoid hemorrhages and diabetes.